Literature DB >> 9539781

Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia.

A M Ford1, C A Bennett, C M Price, M C Bruin, E R Van Wering, M Greaves.   

Abstract

The TEL (ETV6)-AML1 (CBFA2) gene fusion is the most common reciprocal chromosomal rearrangement in childhood cancer occurring in approximately 25% of the most predominant subtype of leukemia- common acute lymphoblastic leukemia. The TEL-AML1 genomic sequence has been characterized in a pair of monozygotic twins diagnosed at ages 3 years, 6 months and 4 years, 10 months with common acute lymphoblastic leukemia. The twin leukemic DNA shared the same unique (or clonotypic) but nonconstitutive TEL-AML1 fusion sequence. The most plausible explanation for this finding is a single cell origin of the TEL-AML fusion in one fetus in utero, probably as a leukemia-initiating mutation, followed by intraplacental metastasis of clonal progeny to the other twin. Clonal identity is further supported by the finding that the leukemic cells in the two twins shared an identical rearranged IGH allele. These data have implications for the etiology and natural history of childhood leukemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539781      PMCID: PMC22533          DOI: 10.1073/pnas.95.8.4584

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Alu RNA transcripts in human embryonal carcinoma cells. Model of post-transcriptional selection of master sequences.

Authors:  D Sinnett; C Richer; J M Deragon; D Labuda
Journal:  J Mol Biol       Date:  1992-08-05       Impact factor: 5.469

2.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

3.  Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens.

Authors:  K P McCarthy; J P Sloane; L M Wiedemann
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes.

Authors:  J V Ravetch; U Siebenlist; S Korsmeyer; T Waldmann; P Leder
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

Review 6.  A natural history for pediatric acute leukemia.

Authors:  M Greaves
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

7.  In utero rearrangements in the trithorax-related oncogene in infant leukaemias.

Authors:  A M Ford; S A Ridge; M E Cabrera; H Mahmoud; C M Steel; L C Chan; M Greaves
Journal:  Nature       Date:  1993-05-27       Impact factor: 49.962

8.  Human immunoglobulin heavy chain genes: evolutionary comparisons of C mu, C delta and C gamma genes and associated switch sequences.

Authors:  T H Rabbitts; A Forster; C P Milstein
Journal:  Nucleic Acids Res       Date:  1981-09-25       Impact factor: 16.971

9.  Immunoglobulin gene organisation and expression in haemopoietic stem cell leukaemia.

Authors:  A M Ford; H V Molgaard; M F Greaves; H J Gould
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event.

Authors:  R Wasserman; N Galili; Y Ito; B A Reichard; S Shane; G Rovera
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  58 in total

1.  The T-ALL paradox in cancer.

Authors:  Trang Hoang; Thu Hoang
Journal:  Nat Med       Date:  2010-11       Impact factor: 53.440

Review 2.  A primitive cell origin for B-cell precursor ALL?

Authors:  C V Cox; A Blair
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

3.  Gender-specific frequency of background somatic mutations at the hypoxanthine phosphoribosyltransferase locus in cord blood T lymphocytes from preterm newborns.

Authors:  M Yoshioka; P M Vacek; T Poseno; R Silver; B A Finette
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

4.  The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ≈0.6% of healthy newborns.

Authors:  Daniel Hein; Karin Dreisig; Markus Metzler; Shai Izraeli; Kjeld Schmiegelow; Arndt Borkhardt; Ute Fischer
Journal:  Blood       Date:  2019-10-17       Impact factor: 22.113

Review 5.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

Review 6.  Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.

Authors:  Kelly Faulk; Lia Gore; Todd Cooper
Journal:  Paediatr Drugs       Date:  2014-06       Impact factor: 3.022

Review 7.  Molecular pathogenesis of MLL-associated leukemias.

Authors:  Mariko Eguchi; Minenori Eguchi-Ishimae; Mel Greaves
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

8.  The acetyltransferase 60 kDa trans-acting regulatory protein of HIV type 1-interacting protein (Tip60) interacts with the translocation E26 transforming-specific leukaemia gene (TEL) and functions as a transcriptional co-repressor.

Authors:  Iver Nordentoft; Poul Jørgensen
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

9.  The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells.

Authors:  Anthony M Ford; Chiara Palmi; Clara Bueno; Dengli Hong; Penny Cardus; Deborah Knight; Giovanni Cazzaniga; Tariq Enver; Mel Greaves
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

Review 10.  A systematic review and meta-analysis of childhood leukemia and parental occupational pesticide exposure.

Authors:  Donald T Wigle; Michelle C Turner; Daniel Krewski
Journal:  Environ Health Perspect       Date:  2009-05-19       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.